Skip to main content
Ganesh Benzoplast Ltd. logo

Ganesh Benzoplast Ltd. — Investor Relations & Filings

Ticker · GANESHBE ISIN · INE388A01029 LEI · 335800ADMLACZ4KJML55 BSE.NS Transportation and storage
Open in API
Filings indexed 927 across all filing types
Latest filing 2022-11-03 Regulatory Filings
Country IN India
Listing BSE.NS GANESHBE

About Ganesh Benzoplast Ltd.

https://www.ganeshbenzoplast.com/

Ganesh Benzoplast Ltd. operates as an independent liquid storage tank provider and a manufacturer of specialty chemicals. The company manages a comprehensive network of bulk liquid storage terminals at major ports, offering infrastructure for the handling and storage of liquid chemicals, petroleum products, and edible oils. Its chemical manufacturing division focuses on the production of food preservatives, specifically sodium benzoate, alongside lubricant additives and plasticizers. The organization provides critical logistics support through its storage facilities and supplies chemical components to the food, automotive, and industrial sectors. By integrating port-based storage solutions with chemical production, the company maintains a significant presence in the midstream logistics and specialty chemical supply chains.

Recent filings

Filing Released Lang Actions
This is to inform you that the Board of Directors of the Company, at their meeting held on November 03, 2022, has considered and approved the following: a) Standalone and Consolidated ....
Regulatory Filings
2022-11-03 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is an invitation and intimation for a conference call scheduled to discuss the unaudited financial results for the quarter and half year ended September 30, 2022. It includes details about the date, time, dial-in numbers, and company management participants. There is no actual financial data or detailed report content included, only an announcement of the conference call event. According to the classification rules, such a document is best classified as a Call Transcript (CT) if it contained the full transcript, but since this is only an invitation and intimation for the call, it fits best under Regulatory Filings (RNS) as a general regulatory announcement. However, given the specific nature of the document as a conference call invitation related to financial results, the most appropriate classification is Call Transcript (CT) category, as it is directly related to the earnings call event, even though the transcript itself is not included. Confidence is high due to clear mention of conference call and financial results discussion.
2022-11-01 English
Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that ....
Regulatory Filings Classification · 95% confidence The document is a notification dated November 1, 2022, addressed to stock exchanges about an upcoming conference call scheduled for November 7, 2022. The call is to discuss the unaudited financial results for the quarter and half year ended September 30, 2022. The text includes dial-in details and RSVP contacts but does not contain any actual financial data or detailed financial analysis. It is an announcement of a conference call related to financial results, not the transcript or the results themselves. Therefore, this document fits the category of a Call Transcript announcement or invitation, but since it is only an invitation and not a transcript, it is best classified as a Regulatory Filing (RNS) as a general announcement. However, given the specific nature of the announcement (conference call on financial results), the closest specific category is Call Transcript (CT) if it were the transcript, but since it is only an invitation, it is not a transcript. The best fit is Regulatory Filings (RNS) as a general announcement of the call. Confidence is high due to clear identification of the document as a conference call invitation without financial data or transcript.
2022-11-01 English
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for November 3, 2022. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2022. The letter references compliance with SEBI Listing Regulations, specifically Regulation 29(1)(a) which mandates intimation of Board Meetings. The document does not contain any financial data or results itself, but is an announcement of the meeting where such results will be approved. The document length is short (1782 characters) and it serves as a notification rather than a report or detailed filing. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to the stock exchanges about the Board Meeting and upcoming financial results approval.
2022-10-27 English
GANESH BENZOPLAST LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2022 ,inter alia, to consider and approve the Standalone & Consolidated ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for November 3, 2022. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2022. The letter references compliance with SEBI Listing Regulations, specifically Regulation 29(1)(a) for board meeting intimation and Regulation 33 for financial results. The document does not contain any financial data or results itself, but is an announcement of a future event where such results will be approved. The document length is short (1475 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance document rather than an Interim Report (IR) or Earnings Release (ER).
2022-10-27 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization activities for the quarter ended September 30, 2022. It is addressed to stock exchanges and signed by the company secretary and the registrar and share transfer agent. The content is a compliance certificate rather than a financial report or announcement of financial results. The document length is short (3042 characters) and it primarily serves as a regulatory compliance confirmation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and confirmations.
2022-10-17 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.